Fertility and Sterility
Volume 85, Issue 5 , Pages 1398-1403 , May 2006

Urinary follicle-stimulating hormone (FSH) is more effective than recombinant FSH in older women in a controlled randomized study

  • Mohamed A. Mohamed, M.D.

      Affiliations

    • Department of Obstetrics, Gynecology and Perinatology, “La Sapienza” University, Rome, Italy
  • ,
  • Marco Sbracia, M.D.

      Affiliations

    • Center for Endocrinology and Reproductive Medicine, Rome, Italy
    • Corresponding Author InformationReprint requests: Marco Sbracia, M.D., Center for Endocrinology and Reproductive Medicine, Via Carlo Porta 10, 00153, Rome, Italy (FAX: 9-06-5880096)
  • ,
  • Arianna Pacchiarotti, M.D.

      Affiliations

    • Department of Obstetrics, Gynecology and Perinatology, “La Sapienza” University, Rome, Italy
  • ,
  • Giulietta Micara, B.S.

      Affiliations

    • Department of Obstetrics, Gynecology and Perinatology, “La Sapienza” University, Rome, Italy
  • ,
  • Antonella Linari, B.S.

      Affiliations

    • Department of Obstetrics, Gynecology and Perinatology, “La Sapienza” University, Rome, Italy
  • ,
  • Daniela Tranquilli, B.S.

      Affiliations

    • Department of Obstetrics, Gynecology and Perinatology, “La Sapienza” University, Rome, Italy
  • ,
  • Salomé M.B. Espinola, B.S.

      Affiliations

    • Department of Obstetrics, Gynecology and Perinatology, “La Sapienza” University, Rome, Italy
  • ,
  • Cesare Aragona, M.D.

      Affiliations

    • Department of Obstetrics, Gynecology and Perinatology, “La Sapienza” University, Rome, Italy

Received 27 June 2005 ,Revised 25 October 2005 ,Accepted 25 October 2005.

References 

  1. Steptoe PG , Edwards RG . Birth after the reimplantation of a human embryo . Lancet . 1978;12:366; 2
  2. Porter RN , Smith W , Craft IL , Abdulwanhid NA , Jacobs HS . Induction of ovulation for in-vitro fertilisation using buserelin and gonadotropins . Lancet . 1984;2:1284–1285
  3. Smitz J, Devroey P, Braeckmans P, Camus M, Van Waesberghe L, Wisanto A, et al. Management of failed cycles in an IVF/GIFT programme with the combination of a GnRH analogue and HMG . Hum Reprod . 1987;4:309–314
  4. Neveu S , Hedon B , Bringer J , Chinchole JM , Arnal F , Humeau C , et al.   Ovarian stimulation by a combination of a gonadotropin-releasing hormone agonist and gonadotropins for in vitro fertilization . Fertil Steril . 1987;47:639–643
  5. Hughes EG , Fedorkow DM , Daya S , Sagle MA , Van de Koppel P , Collins JA . The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer (a meta-analysis of randomized controlled trials) . Fertil Steril . 1992;58:888–896
  6. Recombinant Human FSH Study Group . Clinical assessment of recombinant human follicle-stimulating hormone in stimulating ovarian follicular development before in vitro fertilization . Fertil Steril . 1995;63:77–86
  7. Out HJ , Mannaerts BM , Driessen SG , Bennink HJ . A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle stimulating hormone (Puregon versus Metrodin) in in-vitro fertilization . Hum Reprod . 1995;10:2534–2540
  8. Hedon B , Out HJ , Hugues JN , Camier B , Cohen J , Lopes P , et al.   Efficacy and safety of recombinant follicle stimulating hormone (Puregon) in infertile women pituitary-suppressed with triptorelin undergoing in-vitro fertilization (a prospective, randomized, assessor-blind, multicentre trial) . Hum Reprod . 1995;10:3102–3106
  9. Fisch B, Avrech OM, Pinkas H, Neri A, Rufas O, Ovadia J, et al. Superovulation before IVF by recombinant versus urinary human FSH (combined with a long GnRH analog protocol) (a comparative study) . J Assist Reprod Genet . 1995;12:26–31
  10. Ubaldi F , Camus M , Smitz J , Bennink HC , Van Steirteghem A , Devroey P . Premature luteinization in in vitro fertilization cycles using gonadotropin-releasing hormone agonist (GnRH-a) and recombinant follicle-stimulating hormone (FSH) and GnRH-a and urinary FSH . Fertil Steril . 1996;66:275–280
  11. Bergh C, Howles CM, Borg K, Hamberger L, Josefsson B, Nilsson L, et al. Recombinant human follicle stimulating hormone (r-hFSH; Gonal-F) versus highly purified urinary FSH (Metrodin HP) (results of a randomized comparative study in women undergoing assisted reproductive techniques) . Hum Reprod . 1997;12:2133–2139
  12. Out HJ , Driessen SG , Mannaerts BM , Coelingh Bennink HJ . Recombinant follicle-stimulating hormone (follitropin beta, Puregon) yields higher pregnancy rates in in vitro fertilization than urinary gonadotropins . Fertil Steril . 1997;68:138–142
  13. Jacob S , Drudy L , Conroy R , Harrison RF . Outcome from consecutive in-vitro fertilization/intracytoplasmic sperm injection attempts in the final group treated with urinary gonadotrophins and the first group treated with recombinant follicle stimulating hormone . Hum Reprod . 1998;13:1783–1787
  14. Hoomans EH , Andersen AN , Loft A , Leerentveld RA , van Kamp AA , Zech H . A prospective, randomized clinical trial comparing 150 IU recombinant follicle stimulating hormone (Puregon) and 225 IU highly purified urinary follicle stimulating hormone (Metrodin-HP) in a fixed-dose regimen in women undergoing ovarian stimulation . Hum Reprod . 1999;14:2442–2447
  15. Schats R , Sutter PD , Bassil S , Kremer JA , Tournaye H , Donnez J  Feronia and Apis Study Group . Ovarian stimulation during assisted reproduction treatment (a comparison of recombinant and highly purified urinary human FSH) . Hum Reprod . 2000;15:1691–1697
  16. Ola B , Afnan M , Hammadieh N . Recombinant versus urinary FSH for ovarian stimulation in assisted reproduction . Hum Reprod . 2000;15:1208–1209
  17. Frydman R , Howles CM , Truong F  French Multicentre Trialists . A double-blind, randomized study to compare recombinant human follicle stimulating hormone (FSH; Gonal-F) with highly purified urinary FSH (Metrodin HP) in women undergoing assisted reproductive techniques including intracytoplasmic sperm injection . Hum Reprod . 2000;15:520–525
  18. Lenton E , Soltan A , Hewitt J , Thomson A , Davies W , Ashraf N , et al.   Induction of ovulation in women undergoing assisted reproductive techniques (recombinant human FSH (follitropin alpha) versus highly purified urinary FSH (urofollitropin HP)) . Hum Reprod . 2000;15:1021–1027
  19. Blumenfeld Z . Recombinant FSH vs. urinary FSH—retrospective study of matched pairs for type of treatment (IVF or ICSI) . Fertil Steril . 2001;76:1289–1290
  20. Hugues JN , Bry-Gauillard H , Bstandig B , Uzan M , Cedrin-Durnerin I . Comparison of recombinant and urinary follicle-stimulating hormone preparations in short-term gonadotropin releasing hormone agonist protocol for in vitro fertilization–embryo transfer . J Assist Reprod Genet . 2001;18:191–196
  21. Ravhon A , Lavery S , Aurell R , Trew G , Margara R , Winston R . Clinical experience with recombinant follicle-stimulating hormone (FSH) and urinary FSH (a retrospective case-controlled analysis) . Fertil Steril . 2001;75:920–925
  22. Silverberg K , Daya S , Auray JP , Duru G , Ledger W , Wikland M , et al.   Analysis of the cost effectiveness of recombinant versus urinary follicle-stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection programs in the United States . Fertil Steril . 2002;77:107–113
  23. Goldfarb JM , Desai N . Follitropin-alpha versus human menopausal gonadotropin in an in vitro fertilization program . Fertil Steril . 2003;80:1094–1099
  24. Meden-Vrtovec H , Mocnik-Roznik S , Tomazevic T , Virant-Klun I . Recombinant FSH vs. urinary FSH for ovarian stimulation in in vitro fertilization . J Reprod Med . 2003;48:799–803
  25. Daya S . Updated meta-analysis of recombinant follicle-stimulating hormone (FSH) versus urinary FSH for ovarian stimulation in assisted reproduction . Fertil Steril . 2002;77:711–714
  26. van Wely M , Bayram N , van der Veen F . Recombinant FSH in alternative doses or versus urinary gonadotrophins for ovulation induction in subfertility associated with polycystic ovary syndrome (a systematic review based on a Cochrane review) . Hum Reprod . 2003;18:1143–1149
  27. Pellicer A, Ballester MJ, Serrano MD, Mir A, Serra-Serra V, Remohi J, et al. Aetiological factors involved in the low response to gonadotrophins in infertile women with normal basal serum follicle stimulating hormone levels . Hum Reprod . 1994;9:806–811
  28. Jacobs SL , Metzger DA , Dodson WC , Haney AF . Effect of age on response to human menopausal gonadotropin stimulation . J Clin Endocrinol Metab . 1990;71:1525–1530
  29. Raga F , Bonilla-Musoles F , Casan EM , Bonilla F . Recombinant follicle stimulating hormone stimulation in poor responders with normal basal concentrations of follicle stimulating hormone and oestradiol (improved reproductive outcome) . Hum Reprod . 1999;14:1431–1434
  30. De Placido G , Alviggi C , Mollo A , Strina I , Varricchio MT , Molis M . Recombinant follicle stimulating hormone is effective in poor responders to highly purified follicle stimulating hormone . Hum Reprod . 2000;15:17–20
  31. Veeck LL . An atlas of human gametes and conceptus . London (UK): Parthenon Publishing; 1999;
  32. Sbracia M , Farina A , Poverini R , Morgia F , Schimberni M , Aragona C . Short versus long gonadotropin releasing hormone analogue suppression protocols for superovulation in intracytoplasmic sperm injection patients >40 years . Fertil Steril . 2005;84:644–648
  33. de Leeuw R , Mulders J , Voortman G , Rombout F , Damm J , Kloosterboer L . Structure-function relationship of recombinant follicle stimulating hormone . (Puregon) Mol Hum Reprod . 1996;2:361–369
  34. Flack MR , Bennet AP , Froehlich J , Anasti JN , Nisula BC . Increased biological activity due to basic isoforms in recombinant human follicle-stimulating hormone produced in a human cell line . J Clin Endocrinol Metab . 1994;79:756–760
  35. Matikainen T , De Leeuw R , Mannaerts B , Huhtaniemi I . Circulating bioactive and immunoreactive recombinant human follicle stimulating hormone (Org 32489) after administration to gonadotropin-deficient subjects . Fertil Steril . 1994;61:62–69
  36. Mannaerts BM , Rombout F , Out HJ , Coelingh Bennink H . Clinical profiling of recombinant follicle stimulating hormone (rFSH; Puregon) (relationship between serum FSH and efficacy) . Hum Reprod Update . 1996;2:153–161
  37. Padmanabhan V , Lang LL , Sonstein J , Kelch RP , Beitins IZ . Modulation of serum follicle-stimulating hormone bioactivity and isoform distribution by estrogenic steroids in normal women and in gonadal dysgenesis . J Clin Endocrinol Metab . 1988;67:465–473
  38. Klein NA , Harper AJ , Houmard BS , Sluss PM , Soules MR . Is the short follicular phase in older women secondary to advanced or accelerated dominant follicle development? . J Clin Endocrinol Metab . 2002;87:5746–5750
  39. van Zonneveld P , Scheffer GJ , Broekmans FJ , Blankenstein MA , de Jong FH , Looman CW , et al.   Do cycle disturbances explain the age-related decline of female fertility? Cycle characteristics of women aged over 40 years compared with a reference population of young women . Hum Reprod . 2003;18:495–501
  40. Klein NA , Battaglia DE , Fujimoto VY , Davis GS , Bremner WJ , Soules MR . Reproductive aging (accelerated ovarian follicular development associated with a monotropic follicle-stimulating hormone rise in normal older women) . J Clin Endocrinol Metab . 1996;81:1038–1045

 The work was performed at: Department of Obstetrics, Gynecology and Perinatology, Policlinico Umberto I Hospital, “La Sapienza” University, Rome, Italy.

PII: S0015-0282(06)00093-8

doi: 10.1016/j.fertnstert.2005.10.049

Fertility and Sterility
Volume 85, Issue 5 , Pages 1398-1403 , May 2006